Association between the use of renin-angiotensin system blockers and development of in-hospital atrial fibrillation in patients with ST-segment elevation myocardial infarction
MEDICINA-LITHUANIA, vol.52, no.2, pp.104-109, 2016 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 52 Issue: 2
- Publication Date: 2016
- Doi Number: 10.1016/j.medici.2016.02.006
- Journal Name: MEDICINA-LITHUANIA
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.104-109
- Keywords: Myocardial infarction, Atrial fibrillation, Renin-angiotensin system, CONVERTING ENZYME-INHIBITORS, PROGNOSTIC-SIGNIFICANCE, HEART-FAILURE, RECEPTOR BLOCKERS, CARDIOVERSION, PREVENTION, ENALAPRIL, FREQUENCY
- Süleyman Demirel University Affiliated: Yes
Abstract
Background and aim: Atrial fibrillation (AF) is the most common supraventricular arrhythmia following ST-segment elevation myocardial infarction (STEMI). We evaluated the association between use of previous angiotensin converting enzyme inhibitors and/or angiotensin receptor blockers (renin-angiotensin system [RAS] blockers) and started RAS blockers after MI and development of AF in patients presenting with acute STEMI.